XOOMAR

Enveric Biosciences (ENVB)

Enveric Biosciences on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq.

Download CSV

39K

Short interest

settlement 2026-10-15

1.0

Days to cover

unchanged vs prior

32.8%

Short share of volume

2026-11-02

3,390

Fails to deliver

settlement 2026-10-14

Fri 13 Nov

Next earnings

estimated date

$0

Insider flow, 90 days

0 buys, 0 sells

As of 2026-11-02.

Short interest

FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSON

As of 15 October 2026, short interest in ENVB is 38,702 shares, up 15,830 shares over the last month. Over the last 48 readings it ranged from 12,873 shares (31 August 2026) to 1,239,639 shares (28 February 2025). The latest reading sits at the bottom of that range. At the reported average volume of 73K shares a day that is 1.0 days to cover.

Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/envb" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
PreviewDark previewAdd ?theme=dark to the src for a dark chart.
SettlementShares shortChangeAvg daily volumeDays to cover
2026-10-1538,702+150.7%73,4791.00
2026-09-3015,435-32.5%80,5911.00
2026-09-1522,872+77.7%44,9641.00
2026-08-3112,873-25.4%159,5381.00
2026-08-1417,262-9.7%115,6771.00
2026-07-3119,113+3.2%140,4861.00
2026-07-1518,513+18.1%77,7111.00
2026-06-3015,675-66.2%142,7011.00
2026-06-1546,331+74.3%270,1361.00
2026-05-2926,583-77.1%194,7651.00
2026-05-15115,974-86.9%402,8181.00
2026-04-30886,509+1306.6%20,588,0131.00
2026-04-1563,023-10.9%27,5642.29
2026-03-3170,703-24.8%31,7832.22
2026-03-1393,975-20.6%52,5671.79
2026-02-27118,369+90.8%2,015,8841.00
2026-02-1362,034-20.0%47,4061.31
2026-01-3077,515+14.5%76,6231.01
2026-01-1567,685+7.9%45,9061.47
2025-12-3162,720-45.0%83,6091.00
2025-12-15114,023+161.4%3,539,7881.00
2025-11-2843,623-39.2%32,7681.33
2025-11-1471,782+136.9%213,3421.00
2025-10-3130,303-84.9%45,8501.00
2025-10-15200,607-35.0%880,2261.00
2025-09-30308,597-18.3%1,025,2491.00
2025-09-15377,872-5.0%123,2303.07
2025-08-29397,575+71.1%524,3051.00
2025-08-15232,382-8.9%82,3802.82
2025-07-31255,063+19.5%173,8871.47
2025-07-15213,496-20.6%150,1741.42
2025-06-30269,004+17.8%149,5791.80
2025-06-13228,353-25.0%222,7451.03
2025-05-30304,551+143.3%778,8261.00
2025-05-15125,152-27.3%54,9912.28
2025-04-30172,041-1.3%54,0913.18
2025-04-15174,217-3.0%62,2342.80
2025-03-31179,520-25.5%75,4072.38
2025-03-14241,049-80.5%300,2481.00
2025-02-281,239,639+351.3%17,519,4241.00
2025-02-14274,693+17.8%633,7311.00
2025-01-31233,170-42.8%377,2381.00
2025-01-15407,352+498.4%1,043,3721.00
2024-12-3168,076-56.7%187,3321.00
2024-12-13157,214+36.1%191,3411.00
2024-11-29115,509-57.6%146,0241.00
2024-11-15272,161-17.6%388,6631.00
2024-10-31330,219+70.9%426,5341.00

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 2 November 2026, the short share of ENVB volume is 32.8%, down 5.1 points over the last five sessions. Over the last 30 readings it ranged from 4.2% (22 October 2026) to 56.0% (15 October 2026). The latest reading is 2.5 points above the 30-session average of 30.3%, on 16K shares reported.

DateShort volumeTotal volumeShort shareExempt
2026-11-025K16K32.8%0
2026-10-301K7K20.6%0
2026-10-295K11K43.5%0
2026-10-281K10K14.7%0
2026-10-274K9K39.8%0
2026-10-265K12K37.8%0
2026-10-232K18K9.7%0
2026-10-2297923K4.2%0
2026-10-2119K58K32.7%0
2026-10-2010K19K49.7%0
2026-10-198K23K35.6%0
2026-10-165K12K38.5%0
2026-10-157K13K56.0%0
2026-10-1442K100K42.3%0
2026-10-1328K63K44.5%0
2026-10-1217K57K29.5%0
2026-10-094K21K16.8%0
2026-10-0811K38K30.1%0
2026-10-0710K22K47.7%0
2026-10-065K32K15.2%0
2026-10-0511K39K27.6%0
2026-10-025K29K18.3%0
2026-10-018K46K17.2%0
2026-09-3014K31K45.6%0
2026-09-297K26K26.1%0
2026-09-283K33K8.8%0
2026-09-258K25K32.5%0
2026-09-2412K55K21.3%0
2026-09-2335K82K42.9%0
2026-09-228K27K27.4%0

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 14 October 2026, the fails-to-deliver balance in ENVB is 3,390 shares, down 9,681 shares over the last settlement date. Over the last 30 readings it ranged from 41 shares (2 October 2026) to 13,071 shares (13 October 2026).

SettlementShares failedPriceValue
2026-10-143,390$1.43$5K
2026-10-1313,071$1.46$19K
2026-10-083,586$1.49$5K
2026-10-0241$1.46$60
2026-10-015,450$1.47$8K
2026-09-30537$1.45$779
2026-09-251,990$1.54$3K
2026-09-243,037$1.57$5K
2026-09-181,619$1.59$3K
2026-09-1794$1.49$140
2026-09-15704$1.48$1K
2026-09-101,427$1.46$2K
2026-09-043,394$1.44$5K
2026-08-197,538$1.35$10K
2026-08-122,283$1.55$4K
2026-08-068,470$1.67$14K
2026-07-311,160$1.43$2K
2026-07-271,720$1.29$2K
2026-07-232,001$1.34$3K
2026-07-207,514$1.34$10K
2026-07-131,216$1.36$2K
2026-07-026,363$1.50$10K
2026-06-18212$1.30$276
2026-06-171,041$1.37$1K
2026-06-161,872$1.48$3K
2026-06-155,727$1.53$9K
2026-06-1245$1.66$75
2026-06-112,758$1.62$4K
2026-06-098,506$1.75$15K
2026-05-282,922$2.14$6K

Insider trades

SEC Form 4, newest first. JSON

No open-market insider trades were reported for ENVB in the last 90 days. The most recent filings are listed below. Latest filing: Facchini Peter J. (Chief Innovation Officer) on 2026-06-01.

DateInsiderTitleTypeSharesPriceValueOwned after
2026-06-01Facchini Peter J.Chief Innovation OfficerGrant25K$0.00$028K
2026-06-01Tucker Joseph EdwardChief Executive OfficerGrant201K$0.00$0271K
2026-06-01Kegler George A.DirectorGrant19K$0.00$026K
2026-06-01Schabacker MarcusDirectorGrant19K$0.00$026K
2026-06-01PASQUALONE FRANKDirectorGrant19K$0.00$026K
2026-06-01WEBB MICHAEL DDirectorGrant19K$0.00$026K
2026-06-01DeWitt SheilaDirectorGrant19K$0.00$026K
2026-06-01Coveney Kevin MichaelChief Financial OfficerGrant133K$0.00$0181K
2025-12-23Kegler George A.DirectorGrant8K$0.00$08K
2025-12-23PASQUALONE FRANKDirectorGrant8K$0.00$08K
2025-12-23Schabacker MarcusDirectorGrant8K$0.00$08K
2025-12-23Tucker Joseph EdwardChief Executive OfficerGrant60K$0.00$070K
2025-12-23WEBB MICHAEL DDirectorGrant8K$0.00$08K
2025-12-23DeWitt SheilaDirectorGrant8K$0.00$08K
2025-12-23Coveney Kevin MichaelChief Financial OfficerGrant40K$0.00$047K
2025-05-08Tucker Joseph EdwardCHIEF EXECUTIVE OFFICERGrant99K$0.00$0121K
2025-05-08Facchini Peter J.CHIEF INNOVATION OFFICERGrant25K$0.00$033K
2025-05-08Coveney Kevin MichaelCHIEF FINANCIAL OFFICERGrant74K$0.00$087K
2024-10-09Coveney Kevin MichaelCHIEF FINANCIAL OFFICERGrant100K$0.00$0187K
2024-10-09Facchini Peter J.CHIEF INNOVATION OFFICERGrant40K$0.00$0131K
2024-10-09Tucker Joseph EdwardCHIEF EXECUTIVE OFFICERGrant162K$0.00$0336K
2024-10-09PASQUALONE FRANKDirectorGrant48K$0.00$049K
2024-10-09WEBB MICHAEL DDirectorGrant48K$0.00$048K
2024-10-09Schabacker MarcusDirectorGrant48K$0.00$048K
2024-10-09Kegler George A.DirectorGrant48K$0.00$048K
2024-10-09DeWitt SheilaDirectorGrant28K$0.00$028K
2024-02-22Coveney Kevin MichaelCHIEF FINANCIAL OFFICERGrant60K$0.00$087K
2024-02-22Facchini Peter J.CHIEF INNOVATION OFFICERGrant50K$0.00$091K
2024-02-22Tucker Joseph EdwardCHIEF EXECUTIVE OFFICERGrant100K$0.00$0174K
2023-09-15PASQUALONE FRANKDirectorBuy1K$2.14$2K1K
2023-03-13Coveney Kevin MichaelChief Financial OfficerGrant27K$0.00$027K
2023-01-25Kanubaddi AvaniPresident and COOGrant10K$0.00$048K
2023-01-25Hagel Jillian MarieVice President of InnovationGrant12K$0.00$036K
2023-01-25Tucker Joseph EdwardChief Executive OfficerGrant44K$0.00$074K
2023-01-25Facchini Peter J.Chief Innovation OfficerGrant17K$0.00$041K
2021-10-13Hagel Jillian MarieChief Technology OfficerGrant11K$0.00$024K
2021-10-13Hagel Jillian MarieChief Technology OfficerGrant1K$0.00$013K
2021-10-13Facchini Peter J.Chief Scientific OfficerGrant1K$0.00$013K
2021-10-13Facchini Peter J.Chief Scientific OfficerGrant11K$0.00$024K
2021-10-13Tucker Joseph EdwardChief Executive OfficerGrant1K$0.00$015K
2021-10-13Tucker Joseph EdwardChief Executive OfficerGrant15K$0.00$030K
2021-09-16Tucker Joseph EdwardChief Executive OfficerGrant691Kprice not stated in the filingnot stated691K
2021-09-16Facchini Peter J.Chief Scientific OfficerGrant532Kprice not stated in the filingnot stated532K
2021-09-16Facchini Peter J.Chief Scientific OfficerGrant85Kprice not stated in the filingnot stated85K
2021-09-16Hagel Jillian MarieChief Technology OfficerGrant532Kprice not stated in the filingnot stated532K
2021-09-16Hagel Jillian MarieChief Technology OfficerGrant82Kprice not stated in the filingnot stated82K
2021-09-16Tucker Joseph EdwardChief Executive OfficerGrant691Kprice not stated in the filingnot stated691K
2021-03-18LIND DOUGLASDirectorGrant2K$0.00$02K
2021-03-04Van Buiten JohnChief Financial OfficerGrant25K$0.00$025K
2021-02-15Schabacker MarcusDirectorGrant16K$0.00$016K
2021-02-15Kegler George A.DirectorGrant16K$0.00$016K
2021-02-15Mayer SolomonDirectorGrant16K$0.00$016K

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

2 holders report 5% or more of ENVB in their latest filing, all on Schedule 13G (passive). The largest reported stake is Armistice Capital, LLC at 10.0% of the class (405,092 shares), filed 2026-08-14 for an event on 2026-06-30.

FiledFormHolderSharesOf classEvent
2026-08-1413GArmistice Capital, LLCinvestment adviser, other entity405K10.0%2026-06-30
2026-08-1413GSteven Boydparent holding company, individual405K10.0%2026-06-30
2026-08-1413G/Ano. 2EASTON JEFFindividual52K1.4%2026-06-30
2026-08-1413G/Ano. 2Lind Global Fund III LPpartnership49K1.3%2026-06-30
2026-08-1413G/Ano. 2Lind Global Partners III LLCother entity49K1.3%2026-06-30
2026-08-1313G/Ano. 1Waqas Khatriindividual111K2.9%2026-06-30
2026-08-1313G/Ano. 1Ayrton Capital LLCinvestment adviser111K2.9%2026-06-30
2026-08-1313G/Ano. 1Alto Opportunity Master Fund, SPC - Segregated Master Portfolio Bcorporation111K2.9%2026-06-30
2026-02-0213GIntracoastal Capital LLCother entity71K5.0%2026-01-27
2026-02-0213GMitchell P. Kopinparent holding company, individual71K5.0%2026-01-27
2026-02-0213GDaniel B. Asherparent holding company, individual71K5.0%2026-01-27
2026-01-0513G/Ano. 1AdvisorShares Trustinvestment company17K1.7%2025-12-31
2025-12-1013G/Ano. 1Braeden Lichtipartnership00.0%2025-12-09
2025-12-1013G/Ano. 1Northstrive Fund II LPindividual00.0%2025-12-09

13F holders

Tracked managers holding ENVB at their latest 13F. JSON

2 of the 30 tracked managers held ENVB at their latest 13F, $64K in total at quarter-end prices. Renaissance Technologies is the largest at $44K (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 0 cut.

FundQuarterSharesValueOf portfolioChange in shares
Renaissance Technologies2026-06-3032K$44K0.00%new
Citadel Advisors2026-06-3014K$19K0.00%new

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

What this page is

Enveric Biosciences in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows Enveric Biosciences (ENVB), SEC CIK 890821, listed on Nasdaq. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest
FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
Daily short volume
FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
Fails to deliver
SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-14.JSON and CSV
Large holders
SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-14.JSON and CSV
13F holders
SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
Earnings dates
SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-14.JSON and CSV
Insider trades
SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-06-01.JSON and CSV
Company record
EDGAR filing index for CIK 890821Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits
10 requests a minute without a key, 30 with a free key from a free account.

How to read it

  • Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
  • Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
  • Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Datasets

Frequently Asked Questions

How much of ENVB is sold short?
38,702 shares were held short at the 2026-10-15 settlement, 1.0 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is ENVB's daily short volume?
On 2026-11-02, 5,361 of the 16,355 ENVB shares reported to FINRA were sold short, 32.8% of the day's reported volume. Short volume is a flow for one day, not a position.
Does ENVB have fails to deliver?
The SEC's latest file shows 3,390 ENVB shares failed to deliver at settlement 2026-10-14. Fails are reported per settlement date and published twice a month with a lag.
Are ENVB insiders buying or selling?
No open-market insider trades were reported for ENVB in the last 90 days. The most recent filings are listed below. Latest filing: Facchini Peter J. (Chief Innovation Officer) on 2026-06-01.
Who owns 5% or more of ENVB?
2 holders report 5% or more of ENVB in their latest filing, all on Schedule 13G (passive). The largest reported stake is Armistice Capital, LLC at 10.0% of the class (405,092 shares), filed 2026-08-14 for an event on 2026-06-30.
Which tracked 13F managers own ENVB?
2 of the 30 tracked 13F managers held ENVB shares at their latest filing, $64K in all. The largest: Renaissance Technologies (32K shares, $44K), Ken Griffin's Citadel Advisors (14K shares, $19K).

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.